MD Anderson Board of Visitors celebrates growth and achievement
HOUSTON ― The University of Texas MD Anderson Cancer Center started its fiscal year on a celebratory note by welcoming seven new members to the MD Anderson Cancer Center Board of Visitors (BOV), the institution’s nonfiduciary advisory board. MD Anderson also honors two long-term board members, Donald “Don” L. Evans from Midland and Peggy Sewell from Dallas, with the BOV’s most prestigious title of Life Member.
“These passionate...
MD Anderson Research Highlights Special Edition: ASTRO 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...
Michael Frumovitz, M.D., posthumously honored with Julie and Ben Rogers Award for Excellence
HOUSTON ― The University of Texas MD Anderson Cancer Center has posthumously awarded Michael Frumovitz, M.D., with the Julie and Ben Rogers...
MD Anderson launches first-ever academic journal: Advances in Cancer Education & Quality Improvement
The University of Texas MD Anderson Cancer Center today announced its first-ever academic journal, Advances in Cancer Education & Quality Improvement (ACE-QI). The journal will publish research, training program summaries and quality improvement interventions for the oncology provider community.
The open-access, peer-reviewed journal will feature research and professional perspectives focused on training health care providers...
Allison Institute and Institute for Data Science in Oncology blend spatial biology efforts by appointing new member
The James P. Allison Institute™ and the Institute for Data Science in Oncology (IDSO) at The University of Texas MD Anderson Cancer...
MD Anderson Research Highlights for September 19, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...
Novel triplet regimen yields promising response in advanced-phase chronic myeloid leukemia
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory...
ESMO: Combination therapy reduced agitated delirium in patients with advanced cancers
ABSTRACT: 1476O
BARCELONA, Spain ― Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium,...
ESMO: Novel ADC AZD8205 demonstrates manageable safety profile and preliminary efficacy in first-in-human trial
ABSTRACT: 606O
BARCELONA, Spain – The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety...
MD Anderson and Rice launch initiative to advance cancer-focused operations research
The University of Texas MD Anderson Cancer Center and Rice University today announced the launch of the Center for Operations Research in...
MD Anderson Research Highlights Special Edition: ESMO 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer...
MD Anderson Research Highlights Special Edition: 2024 World Conference on Lung Cancer
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer...
MD Anderson Research Highlights for September 4, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...